核医学検査装置の世界市場：SPECT、PET、シンチグラフィ...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Industry Insights
2.2.2.2 Key Data From Primary Sources
2.2.2.3 Key Insights From Primary Sources
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions

3 Executive Summary (Page No. – 29)
3.1 Current Scenario
3.2 Future Outlook
3.3 Conclusion

4 Premium Insights (Page No. – 33)
4.1 Global Nuclear Medicine Equipment Market
4.2 Nuclear Medicine Equipment Market, By Application and End User

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Introduction of New and Advanced Products
5.3.1.2 Investments Through Public-Private Partnerships to Modernize Diagnostic Imaging Centers
5.3.1.3 Advances in Radiotracers
5.3.1.4 Increasing Incidence and Prevalence of Cancer and Cardiac Ailments
5.3.1.5 Growing Geriatric Population
5.3.1.6 Increasing Investments, Funds, and Grants By Government Bodies Worldwide
5.3.2 Restraints
5.3.2.1 High Cost of Nuclear Medicine Equipment
5.3.2.2 Shorter Half-Life of Radiopharmaceuticals
5.3.3 Challenges
5.3.3.1 Increasing Adoption of Refurbished Diagnostic Imaging Systems
5.3.3.2 Hospital Budget Cuts
5.3.4 Opportunities
5.3.4.1 Strong Product Pipeline
5.3.4.2 High Demand in Emerging Markets

6 Nuclear Medicine Equipment Market, By Product (Page No. – 47)
6.1 Introduction
6.2 Single Photon-Emission Computed Tomography (SPECT)
6.2.1 Standalone SPECT Systems
6.2.2 Hybrid SPECT Systems
6.3 Hybrid Pet
6.4 Planar Scintigraphy

7 Nuclear Medicine Equipment Market, By Application (Page No. – 56)
7.1 Introduction
7.2 Cardiology
7.3 Oncology
7.4 Neurology
7.5 Other Applications

8 Nuclear Medicine Equipment Market, By End User (Page No. – 64)
8.1 Introduction
8.2 Hospitals
8.3 Imaging Centers
8.4 Academic and Research Centers
8.5 Other End Users

9 Nuclear Medicine Equipment Market, By Region (Page No. – 70)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Increased Adoption of Nuclear Medicine Equipment
9.2.1.2 Increase in the Aging Population and Rising Prevalence of Chronic Diseases
9.2.1.3 Declining Reimbursements for Radiology
9.2.1.4 Unfavorable Healthcare Reforms
9.2.2 Canada
9.2.2.1 High Incidence Rate Chronic Diseases
9.3 Europe
9.3.1 EU5
9.3.1.1 Increasing Number of Pet-Ct Procedures in the U.K.
9.3.1.2 Increasing Adoption of Nuclear Medicine Equipment
9.3.1.3 Increasing Incidence and Prevalence of Cancer
9.3.1.4 Increasing Investment By Stakeholders
9.3.1.5 Sluggish Growth in Healthcare Expenditure
9.3.2 RoE
9.3.2.1 Government and Public-Private Investments
9.3.2.2 Increased Focus of Market Players
9.3.2.3 Rapid Rise in the Geriatric Population
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.1.1 Aging Population and High Healthcare Expenditure in Japan
9.4.2 China
9.4.2.1 Developing Healthcare Infrastructure
9.4.2.2 Rise in Population, Prevalence of Diseases
9.4.2.3 Irregularities in the Tendering Process
9.4.3 India
9.4.3.1 High Incidence and Prevalence of Chronic Diseases
9.4.3.2 Increasing Installations of Nuclear Medicine Equipment
9.4.3.3 Increasing Focus of Global Market Players
9.4.3.4 Improving Healthcare Insurance Coverage
9.4.3.5 Increasing Use of Refurbished Medical Devices A Major Challenge for Market Players
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.4.4.1 Increasing Incidence of Chronic Disease, Growing Geriatric Population
9.4.4.2 Favorable Regulatory Changes in New Zealand and Australia
9.4.4.3 Increasing Public-Private Investments
9.5 Rest of the World
9.5.1 Latin America
9.5.1.1 Favorable Reimbursement Scenario in Brazil
9.5.1.2 Consolidation of Healthcare Service Providers in Brazil
9.5.1.3 Growing Healthcare Infrastructure in Latin America
9.5.2 The Middle East
9.5.3 Africa

10 Competitive Landscape (Page No. – 117)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 New Product Launches
10.3.2 Expansions
10.3.3 Acquisitions
10.3.4 Other Strategies

11 Company Profiles (Page No. – 128)
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Introduction
11.2 Philips Healthcare
11.3 Siemens AG (Siemens Healthcare)
11.4 GE Healthcare
11.5 Digirad Corporation
11.6 Mediso Medical Imaging Systems Ltd.
11.7 Surgiceye GmbH
11.8 Toshiba Medical Systems Corporation
11.9 Ddd-Diagnostic A/S
11.10 Neusoft Medical Systems Co., Ltd.
11.11 CMR Naviscan Corporation

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 150)
12.1 Discussion Guide
12.2 Company Developments (2012–2015)
12.2.1 Philips Healthcare
12.2.2 Siemens Healthcare
12.2.3 GE Healthcare
12.2.4 Digirad Corporation
12.2.5 Toshiba Medical Systems Corporation
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports